Get a sneak peek at clinical results for ASH2023! New ASH2023 clinical results updated on the Synapse database

The American Society of Hematology (ASH) Annual Meeting, established in 1958, is the world's largest event in hematology. As one of the largest medical conferences in the United States, the ASH meeting presents the most anticipated frontiers and research developments in the global field of hematology each year. The 65th ASH, to be held in December 2023 in the United States, is expected to attract over 27,000 hematologists and professionals from more than 100 countries worldwide.

New data from the 2023 ASH conference is now available on the Clinical Results section of the Synapse database. As of November 13th, the database includes 981 entries, comprising a comprehensive summary of 288 principal evaluated drugs, 196 diseases, 188 target points, and 179 institutions.

According to the analysis of the Synapse database, organizations from the United States dominated the data quantity, making up 46.9% of the total, with China following behind at 26.8%.

From the perspective of indications distribution, the indication with the most data revealed at the meeting is Acute Myeloid Leukemia, followed by Multiple Myeloma, Chronic B-cell Lymphocytic Leukemia, Recurrent Multiple Myeloma, and Diffuse Large B-Cell Lymphoma.

In this conference, the drug with the most information disclosed is Venetoclax. Venetoclax is a selective and orally bioavailable small molecule inhibitor of BCL-2, an anti-apoptotic protein. It was first approved by the FDA on April 11, 2016, for use in chronic lymphocytic leukemia (CLL) with a 17p chromosome deletion, as a second-line therapy for patients who have failed one or more treatment regimes or whose disease has progressed.

The conference information involves a significant number of targets such as: DNA, Bcl-2, CD3, CD19, CD20, BTK, etc.

How to search and view the clinical trial results data of your interest through the Synapse database?

Please click on the link to go directly to the search interface to query clinical results.

Select ASH 2023 under the meetings option and click search. You will obtain the full data of ASH 2023. Meanwhile, the clinical results database provides multi-dimensional filtering and screening capabilities for drugs, indications, targets, companies, etc., to help you quickly locate the required data.

On the search page, a card-based list view is provided, allowing you to intuitively obtain the core information of a single result.

Click on the title to jump to the details page to view all the data for this result.

In the key indicators section, we provide the core indicator data information clearly in both list and flow chart forms. At the same time, we offer the function of downloading and saving images.

Finally, if you need to download these results, you can conveniently check the box on the left side of the list, or directly click the "Export" button to download the data for personalized analysis and file sharing.

Currently, the clinical results repository has covered data sources including conferences, ClinicalTrials.gov, Pubmed, news, and instructions manuals, etc. We will continue to expand to new data sources and constantly improve the functionality and data of the results database.

Try it now!